Cognito Raises $105M for Alzheimer’s Device
March 9, 2026
Cognito Therapeutics closes oversubscribed $105M Series C to fund pivotal Alzheimer's trial readout and 2027 launch of Spectris neuromodulation device using light/sound.
March 9, 2026
Cognito Therapeutics closes oversubscribed $105M Series C to fund pivotal Alzheimer's trial readout and 2027 launch of Spectris neuromodulation device using light/sound.